WallStSmart
DCOY

Decoy Therapeutics Inc.

NASDAQ: DCOY · HEALTHCARE · BIOTECHNOLOGY

$5.54
+1.19% today

Updated 2026-04-29

Market cap
$2.89M
P/E ratio
P/S ratio
15.86x
EPS (TTM)
$-129.10
Dividend yield
52W range
$5 – $239
Volume
0.1M

WallStSmart proprietary scores

26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
5.0
Quality
C+
3.0
Profitability
D
5.0
Valuation
C+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target
$30.00
+441.52%
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

X-Ray snapshot

Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-1.14M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-31.61M$-12.54M$-5.58M$-12.52M$-8.98M
EPS$-129.10
Free cash flow$-19.10M$-12.85M$-4.53M$-5.40M$-1.14M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
DCOY$2.89M264.33.05.05.0Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Decoy Therapeutics Inc. trades at $5.54. Our Smart Value Score of 26/100 indicates the stock is weak.

Frequently asked questions

What is Decoy Therapeutics Inc.'s stock price?
Decoy Therapeutics Inc. (DCOY) trades at $5.54.
Is Decoy Therapeutics Inc. overvalued?
Smart Value Score 26/100 (Grade F, Strong Sell).
What is the price target of Decoy Therapeutics Inc. (DCOY)?
The analyst target price is $30.00, representing +441.5% upside from the current price of $5.54.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio15.86x
ROE-338.30%
Beta0.37
50D MA$7.24
200D MA$36.38
Shares out0.00B
Float0.00B
Short ratio
Avg volume0.1M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years